CCS
EMN icon

Crosspoint Capital Strategies’s Eastman Chemical EMN Stock Holding History

Crosspoint Capital Strategies’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-195
Closed -$15K – 307
2015
Q4 		$15K Buy
195
+187
+2,338% +$13.1K ﹤0.01% 641
2015
Q3 		$1K Buy
+8
New +$591 ﹤0.01% 673

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Crosspoint Capital Strategies's EMN Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of Eastman Chemical (EMN) in Q1 2016, closing a stake of 195 shares — an estimated $15K sold.

Crosspoint Capital Strategies first reported a position in EMN in Q3 2015 and held it in 2 quarters. The position peaked at $15K in Q4 2015. 572 funds tracked by Wall St. Rank hold EMN as of Q1 2016.

  • Crosspoint Capital Strategies reported no remaining Eastman Chemical position as of Q1 2016 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 195 Eastman Chemical shares in Q1 2016, an estimated $15K.
  • Crosspoint Capital Strategies first reported a position in Eastman Chemical in Q3 2015 and held it in 2 quarters.
  • Crosspoint Capital Strategies's Eastman Chemical position peaked at $15K in Q4 2015.
  • 572 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.